Poland · Delayed Price · Currency is PLN Read-Gene Statistics
Total Valuation
Read-Gene has a market cap or net worth of PLN 58.36 million. The enterprise value is 61.31 million.
| Market Cap | 58.36M |
| Enterprise Value | 61.31M |
Important Dates
The last earnings date was Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Read-Gene has 11.79 million shares outstanding.
| Current Share Class | 1.49M |
| Shares Outstanding | 11.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.16% |
| Owned by Institutions (%) | n/a |
| Float | 1.27M |
Valuation Ratios
The trailing PE ratio is 113.87.
| PE Ratio | 113.87 |
| Forward PE | n/a |
| PS Ratio | 3.50 |
| PB Ratio | 17.02 |
| P/TBV Ratio | 17.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 119.63 |
| EV / Sales | 3.68 |
| EV / EBITDA | 46.88 |
| EV / EBIT | 72.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.58, with a Debt / Equity ratio of 2.42.
| Current Ratio | 10.58 |
| Quick Ratio | 10.50 |
| Debt / Equity | 2.42 |
| Debt / EBITDA | 6.35 |
| Debt / FCF | -2.59 |
| Interest Coverage | 2.55 |
Financial Efficiency
Return on equity (ROE) is 16.15% and return on invested capital (ROIC) is 11.44%.
| Return on Equity (ROE) | 16.15% |
| Return on Assets (ROA) | 3.38% |
| Return on Invested Capital (ROIC) | 11.44% |
| Return on Capital Employed (ROCE) | 6.19% |
| Weighted Average Cost of Capital (WACC) | 5.41% |
| Revenue Per Employee | 832,933 |
| Profits Per Employee | 25,627 |
| Employee Count | 20 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 207.63 |
Taxes
In the past 12 months, Read-Gene has paid 50,079 in taxes.
| Income Tax | 50,079 |
| Effective Tax Rate | 8.90% |
Stock Price Statistics
The stock price has decreased by -18.03% in the last 52 weeks. The beta is 0.26, so Read-Gene's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -18.03% |
| 50-Day Moving Average | 4.89 |
| 200-Day Moving Average | 5.32 |
| Relative Strength Index (RSI) | 50.42 |
| Average Volume (20 Days) | 376 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Read-Gene had revenue of PLN 16.66 million and earned 512,530 in profits.
| Revenue | 16.66M |
| Gross Profit | 15.72M |
| Operating Income | 843,224 |
| Pretax Income | 562,609 |
| Net Income | 512,530 |
| EBITDA | 1.31M |
| EBIT | 843,224 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 5.35 million in cash and 8.30 million in debt, with a net cash position of -2.95 million or -0.25 per share.
| Cash & Cash Equivalents | 5.35M |
| Total Debt | 8.30M |
| Net Cash | -2.95M |
| Net Cash Per Share | -0.25 |
| Equity (Book Value) | 3.43M |
| Book Value Per Share | n/a |
| Working Capital | 8.03M |
Cash Flow
In the last 12 months, operating cash flow was -2.75 million and capital expenditures -452,692, giving a free cash flow of -3.20 million.
| Operating Cash Flow | -2.75M |
| Capital Expenditures | -452,692 |
| Depreciation & Amortization | 464,556 |
| Net Borrowing | n/a |
| Free Cash Flow | -3.20M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 94.35%, with operating and profit margins of 5.06% and 3.08%.
| Gross Margin | 94.35% |
| Operating Margin | 5.06% |
| Pretax Margin | 3.38% |
| Profit Margin | 3.08% |
| EBITDA Margin | 7.85% |
| EBIT Margin | 5.06% |
| FCF Margin | n/a |
Dividends & Yields
Read-Gene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.88% |
| FCF Yield | -5.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |